Literature DB >> 27152135

Lymphadenectomy in gastric cancer: Contentious issues.

Pankaj Kumar Garg1, Ashish Jakhetiya1, Jyoti Sharma1, Mukur Dipi Ray1, Durgatosh Pandey1.   

Abstract

The stomach is the sixth most common cause of cancer worldwide. Surgery is an important component of the multi-modality treatment of the gastric cancer. The extent of lymphadenectomy has been a controversial issue in the surgical management of gastric cancer. The East-Asian surgeons believe that quality-controlled extended lymphadenectomy resulting in better loco-regional control leads to survival benefit in the gastric cancer; contrary to that, many western surgeons believe that extended lymphadenectomy adds to only postoperative morbidity and mortality without significantly enhancing the overall survival. We present a comprehensive review of the lymphadenectomy in the gastric cancer based on the previously published randomized controlled trials.

Entities:  

Keywords:  Disease recurrence; Gastrectomy; Gastric neoplasms; Lymphadenectomy; Survival

Year:  2016        PMID: 27152135      PMCID: PMC4840168          DOI: 10.4240/wjgs.v8.i4.294

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  27 in total

1.  Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.

Authors:  R E Schwarz
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Basic principles in surgical oncology.

Authors:  B Cady
Journal:  Arch Surg       Date:  1997-04

4.  Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit.

Authors:  Durgatosh Pandey; Rambha Pandey; Pankaj Kumar Garg
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

5.  Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy.

Authors:  Abraham El-Sedfy; Matthew Dixon; Rajini Seevaratnam; Alina Bocicariu; Roberta Cardoso; Alyson Mahar; Alex Kiss; Lucy Helyer; Calvin Law; Natalie G Coburn
Journal:  Ann Surg Oncol       Date:  2014-10-28       Impact factor: 5.344

6.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

7.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

Authors:  Ilfet Songun; Hein Putter; Elma Meershoek-Klein Kranenbarg; Mitsuru Sasako; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2010-04-19       Impact factor: 41.316

8.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

9.  Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer.

Authors:  Yutaka Yonemura; Cheng-Chung Wu; Norimasa Fukushima; Ichirou Honda; Etsurou Bandou; Taiichi Kawamura; Tohru Kamata; Byung-Sik Kim; Nobuo Matsuki; Toshiharu Sawa; Sung-Hoon Noh
Journal:  Int J Clin Oncol       Date:  2008-05-08       Impact factor: 3.402

Review 10.  Multimodal treatment of gastric cancer.

Authors:  Ilaria Proserpio; Stefano Rausei; Sabrina Barzaghi; Francesco Frattini; Federica Galli; Domenico Iovino; Francesca Rovera; Luigi Boni; Gianlorenzo Dionigi; Graziella Pinotti
Journal:  World J Gastrointest Surg       Date:  2014-04-27
View more
  3 in total

1.  Lack of Oncological Benefit from Bursectomy in Radical Gastrectomy: A Systematic Review.

Authors:  Pankaj Kumar Garg; Ashish Jakhetiya; Kiran Kalyan Turaga; Rahul Kumar; Andreas Brandl; Beate Rau
Journal:  Visc Med       Date:  2021-09-09

2.  Impact of the introduction of formal D2 lymphadenectomy for gastric cancer in a Western setting.

Authors:  Alexandre Brind'Amour; Jean-Pierre Gagné; Jean-Charles Hogue; Éric Poirier
Journal:  Can J Surg       Date:  2021-03-02       Impact factor: 2.089

3.  Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer in middle-low-volume centers in Western countries: a propensity score matching analysis.

Authors:  Giovanni Maria Garbarino; Gianluca Costa; Giovanni Guglielmo Laracca; Giorgio Castagnola; Paolo Mercantini; Massimiliano Di Paola; Simone Vita; Luigi Masoni
Journal:  Langenbecks Arch Surg       Date:  2020-08-04       Impact factor: 3.445

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.